Can reduced antibody reserve increase recurrent infection risk?

The claim is supported: diminished humoral immune reserve can raise infection susceptibility, and recurrent or persistent antigen exposure can sustain B-cell and antibody-production activity. These processes are biologically linked but should not be inferred from antibody tests alone.

Clinical evidence

• In rituximab-treated rheumatoid arthritis, baseline IgG <6 g/L predicted more severe infections over the following year than IgG ≥6 g/L (20.7% vs 5.1%; adjusted OR 4.9, 95% CI 1.6–15.2).
• In a large rituximab-treated multiple-sclerosis cohort, IgG <500 mg/dL, versus ≥700 mg/dL, was associated with greater serious-infection risk (adjusted HR 2.98) and outpatient-infection risk (adjusted HR 2.06).
• These data support clinically meaningful risk from reduced antibody reserve, though they derive largely from adults receiving B-cell-depleting therapy. A single low immunoglobulin value does not, by itself, establish functional antibody failure or predict risk for every individual.

Mechanistic evidence

• Repeated or persistent antigen exposure can reactivate antigen-specific memory B cells. Activated cells proliferate and differentiate into plasmablasts and plasma cells, sustaining antigen-specific antibody secretion while antigen remains available.
• Ongoing stimulation need not yield effective protection: chronic HIV can produce activated/atypical memory B cells and plasmablast expansion alongside depletion of resting memory B cells, while chronic hepatitis B may preserve antigen-specific B cells but impair their differentiation into antibody-secreting cells.

Clinical implications

• For recurrent infections, interpretation should integrate IgG, IgA, and IgM with infection frequency, severity, sites, organisms, antibiotic use, and hospitalizations. Where appropriate, pre- and post-vaccination responses, often pneumococcal antibodies, assess antibody function.
• IgG positivity commonly reflects past infection or vaccination; long-lived plasma cells can maintain antibodies without ongoing exposure. Isolated IgM may persist or be falsely positive.

Bottom line

• Reduced antibody reserve can materially increase recurrent-infection risk, and repeated antigen exposure can sustain humoral demand, but individual risk and evidence of ongoing exposure require clinical context and functional immune testing.